Deutsche Bank’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-26,785
| Closed | -$1.93M | – | 4822 |
|
|
2020
Q4 | $1.93M | Buy |
26,785
+6,831
| +34% | +$358K | ﹤0.01% | 1961 |
|
|
2020
Q3 | $910K | Buy |
19,954
+1,377
| +7% | +$57.6K | ﹤0.01% | 2260 |
|
|
2020
Q2 | $839K | Sell |
18,577
-11,025
| -37% | -$494K | ﹤0.01% | 2337 |
|
|
2020
Q1 | $1.14M | Sell |
29,602
-2,179
| -7% | -$100K | ﹤0.01% | 2015 |
|
|
2019
Q4 | $1.47M | Sell |
31,781
-5,211
| -14% | -$226K | ﹤0.01% | 2155 |
|
|
2019
Q3 | $1.5M | Buy |
36,992
+11,759
| +47% | +$508K | ﹤0.01% | 2077 |
|
|
2019
Q2 | $1.21M | Sell |
25,233
-163,879
| -87% | -$8.61M | ﹤0.01% | 2710 |
|
|
2019
Q1 | $11.8M | Sell |
189,112
-121,639
| -39% | -$8.36M | 0.01% | 1279 |
|
|
2018
Q4 | $18.6M | Buy |
310,751
+147,825
| +91% | +$8.88M | 0.01% | 926 |
|
|
2018
Q3 | $10.5M | Sell |
162,926
-3,636
| -2% | -$203K | 0.01% | 1591 |
|
|
2018
Q2 | $7.5M | Buy |
166,562
+66,452
| +66% | +$2.65M | ﹤0.01% | 1984 |
|
|
2018
Q1 | $3.11M | Buy |
100,110
+30,119
| +43% | +$990K | ﹤0.01% | 2575 |
|
|
2017
Q4 | $2.09M | Buy |
69,991
+40,243
| +135% | +$1.17M | ﹤0.01% | 2689 |
|
|
2017
Q3 | $979K | Sell |
29,748
-6,454
| -18% | -$224K | ﹤0.01% | 3033 |
|
|
2017
Q2 | $1.21M | Buy |
36,202
+23,580
| +187% | +$703K | ﹤0.01% | 2889 |
|
|
2017
Q1 | $364K | Sell |
12,622
-5,498
| -30% | -$136K | ﹤0.01% | 3262 |
|
|
2016
Q4 | $403K | Sell |
18,120
-22,611
| -56% | -$442K | ﹤0.01% | 3307 |
|
|
2016
Q3 | $755K | Sell |
40,731
-18,299
| -31% | -$345K | ﹤0.01% | 2994 |
|
|
2016
Q2 | $961K | Buy |
59,030
+14,544
| +33% | +$214K | ﹤0.01% | 2924 |
|
|
2016
Q1 | $519K | Sell |
44,486
-30,497
| -41% | -$341K | ﹤0.01% | 3187 |
|
|
2015
Q4 | $873K | Sell |
74,983
-318,000
| -81% | -$4.02M | ﹤0.01% | 2966 |
|
|
2015
Q3 | $4.81M | Buy |
392,983
+353,649
| +899% | +$4.51M | ﹤0.01% | 1842 |
|
|
2015
Q2 | $370K | Sell |
39,334
-52,358
| -57% | -$484K | ﹤0.01% | 3568 |
|
|
2015
Q1 | $811K | Sell |
91,692
-289
| -0.3% | -$2.92K | ﹤0.01% | 2999 |
|
|
2014
Q4 | $922K | Buy |
91,981
+90,735
| +7,282% | +$778K | ﹤0.01% | 3260 |
|
|
2014
Q3 | $8K | Buy |
1,246
+107
| +9% | +$750 | ﹤0.01% | 5465 |
|
|
2014
Q2 | $8K | Sell |
1,139
-3,939
| -78% | -$31.3K | ﹤0.01% | 5565 |
|
|
2014
Q1 | $51K | Buy |
5,078
+4,078
| +408% | +$37.5K | ﹤0.01% | 4543 |
|
|
2013
Q4 | $7K | Sell |
1,000
-131
| -12% | -$1.22K | ﹤0.01% | 4986 |
|
|
2013
Q3 | $10K | Buy |
1,131
+631
| +126% | +$4.97K | ﹤0.01% | 5056 |
|
|
2013
Q2 | $2K | Buy |
+500
| New | +$1.68K | ﹤0.01% | 5217 |
|
Other funds holding BEAT
Deutsche Bank's BEAT Position: Q1 2021 in Review
Deutsche Bank sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 26,785 shares — an estimated $1.93M sold.
Deutsche Bank first reported a position in BEAT in Q2 2013 and held it in 31 quarters. The position peaked at $18.6M in Q4 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Deutsche Bank reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Deutsche Bank sold 26,785 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.93M.
- Deutsche Bank first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 31 quarters.
- Deutsche Bank's BioTelemetry, Inc. position peaked at $18.6M in Q4 2018.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Deutsche Bank's 13F filing for Q1 2021, filed 13 May 2021.